Home

About Us

ALSA Ventures is a London based international life science investor focused on novel therapeutics.

With a background in the pharmaceutical, biotechnology and CRO industries, our investment team brings a wealth of practical experience to portfolio companies from spinoff to public market listing.
Portfolio

Investment Portfolio

Meet The Alsa Team

Our team brings a rich background of pharmaceutical, biotechnology and CRO drug development expertise to companies we invest in

Alek Safarian

CEO

Graeme Martin

Venture Partner

Robert Balfour

Investment Director

Sohaib Mir

Investment Director

Julia Jones

Investment Manager

IGEM Therapeutics announces final close of £5 million Series A financing round

IGEM Therapeutics announces final close of £5 million Series A financing round New investors Alsa Holdings and UCL Technology Fund join Epidarex Capital Proceeds will allow IGEM to continue development of IgE therapeutic antibody portfolio and novel IgE-based platform technology London, November 30th, 2018– IGEM Therapeutics (IGEM or “the Company”), an immuno-oncology company developing novel […]

Scroll to top